During the past decade, The Corvallis Clinic, P.C. conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 17 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Corvallis Clinic, P.C." #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "AstraZeneca" with 2 trials sponsored, "Ventus Medical, Inc." with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored and "ARCA Biopharma, Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Corvallis Clinic, P.C." #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "American Academy of Orthopaedic Manual Physical Therapists" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Tanox" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "The Corvallis Clinic, P.C." are "Type 2 Diabetes Mellitus" (5 trials), "Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes" (3 trials), "Alzheimer's Disease" (2 trials) and "OSAH" (2 trials). Many other conditions were trialed in "The Corvallis Clinic, P.C." in a lesser frequency.

Most popular intervention types in "The Corvallis Clinic, P.C." are "Drug" (22 trials), "Other" (4 trials), "Biological" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Tirzepatide" (6 trials), "Dulaglutide" (3 trials), "Insulin Degludec" (2 trials) and "Lanabecestat" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Corvallis Clinic, P.C." are 26 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Corvallis Clinic, P.C.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in The Corvallis Clinic, P.C., 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Corvallis Clinic, P.C., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".